1752 – Anal human papillomavirus and cytology testing in high-risk populations

Page last updated: 25 May 2023

Application Detail

Description of Medical Service

An anal human papillomavirus (HPV) test collects cells from the anal cavity via a swab, to detect abnormalities or the presence of cancer. This application proposes extending the existing cervical HPV testing and cytology MBS item numbers to include the anal canal, for patients at high-risk for high-grade squamous intraepithelial lesion and anal squamous cell carcinoma.

Description of Medical Condition

Anal cancer is a cancer that affects the tissues of the anus. Most anal cancers are squamous cell carcinomas. Squamous cells are a type of cell that line the surface of the anal canal.

Reason for Application

Amendment of exisiting MBS item

Medical Service Type

Investigative technology

Previous Application Number/s

Not Applicable

Associated Documentation

Application Summary and PICO Set

Application Summary (PDF 425 KB)
Application Summary (Word 30 KB)

PICO Set (PDF 1156 KB)
PICO Set (Word 206 KB)

Consultation Survey

Consultation Survey (PDF 653 KB)
Consultation Survey (Word 27 KB)

PASC Consultation
PASC consultation closes 7 July 2023

MSAC Consultation
MSAC consultation TBA – please subscribe to the MSAC email bulletin to be notified when consultation opens for this application.

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation


Assessment Report


Public Summary Document


Meetings for this Application


10-11 August 2023